miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer

Background. Gastric cancer (GC) is an important malignant disease around the world. Abnormalities of microRNAs (miRNAs) have been implicated in carcinogenesis of various cancers. In the present study, we examined miR-21 expression in human gastric cancer with lymph node metastasis and attempted to u...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuejuan Xu, Jue Sun, Jianhua Xu, Qi Li, Yuewu Guo, Qiang Zhang
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2012/640168
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849396456008450048
author Yuejuan Xu
Jue Sun
Jianhua Xu
Qi Li
Yuewu Guo
Qiang Zhang
author_facet Yuejuan Xu
Jue Sun
Jianhua Xu
Qi Li
Yuewu Guo
Qiang Zhang
author_sort Yuejuan Xu
collection DOAJ
description Background. Gastric cancer (GC) is an important malignant disease around the world. Abnormalities of microRNAs (miRNAs) have been implicated in carcinogenesis of various cancers. In the present study, we examined miR-21 expression in human gastric cancer with lymph node metastasis and attempted to uncover its relationship with clinicopathologic data, especially with lymph node metastasis. Materials and Methods. The expression levels of miR-21 in the tumor specimens of GC patients were quantified by RT-PCR. The correlation between miR-21 level and multiple clinicopathological factors was then examined by Mann-Whitney test, Kaplan-Meier survival analysis, and operating characteristic (ROC) analysis. Results. The expression level of miR-21 was higher in GC patients with lymph node metastasis than in those without lymph node metastasis (P<0.05). Expression level of miR-21 was significantly correlated with histologic type, T stage, lymph node metastasis and pTNM stage. The overall survival rates in GC patients with low upregulated miR-21 expression were significantly higher than those with high upregulated miR-21 (P<0.05). Conclusion. A close association is implicated between the elevated miR-21and lymph node metastasis, which could potentially be exploited as a practical biomarker for lymph node metastasis in patients with GC.
format Article
id doaj-art-b2db907b8b9f41c0b72d84a24fc828e9
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-b2db907b8b9f41c0b72d84a24fc828e92025-08-20T03:39:19ZengWileyGastroenterology Research and Practice1687-61211687-630X2012-01-01201210.1155/2012/640168640168miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric CancerYuejuan Xu0Jue Sun1Jianhua Xu2Qi Li3Yuewu Guo4Qiang Zhang5Department of Oncology, The Second Hospital of Nanjing, South East University, Nanjing 210003, ChinaDepartment of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, ChinaDepartment of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, ChinaDepartment of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, ChinaDepartment of Oncology, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200233, ChinaDepartment of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, ChinaBackground. Gastric cancer (GC) is an important malignant disease around the world. Abnormalities of microRNAs (miRNAs) have been implicated in carcinogenesis of various cancers. In the present study, we examined miR-21 expression in human gastric cancer with lymph node metastasis and attempted to uncover its relationship with clinicopathologic data, especially with lymph node metastasis. Materials and Methods. The expression levels of miR-21 in the tumor specimens of GC patients were quantified by RT-PCR. The correlation between miR-21 level and multiple clinicopathological factors was then examined by Mann-Whitney test, Kaplan-Meier survival analysis, and operating characteristic (ROC) analysis. Results. The expression level of miR-21 was higher in GC patients with lymph node metastasis than in those without lymph node metastasis (P<0.05). Expression level of miR-21 was significantly correlated with histologic type, T stage, lymph node metastasis and pTNM stage. The overall survival rates in GC patients with low upregulated miR-21 expression were significantly higher than those with high upregulated miR-21 (P<0.05). Conclusion. A close association is implicated between the elevated miR-21and lymph node metastasis, which could potentially be exploited as a practical biomarker for lymph node metastasis in patients with GC.http://dx.doi.org/10.1155/2012/640168
spellingShingle Yuejuan Xu
Jue Sun
Jianhua Xu
Qi Li
Yuewu Guo
Qiang Zhang
miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer
Gastroenterology Research and Practice
title miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer
title_full miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer
title_fullStr miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer
title_full_unstemmed miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer
title_short miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer
title_sort mir 21 is a promising novel biomarker for lymph node metastasis in patients with gastric cancer
url http://dx.doi.org/10.1155/2012/640168
work_keys_str_mv AT yuejuanxu mir21isapromisingnovelbiomarkerforlymphnodemetastasisinpatientswithgastriccancer
AT juesun mir21isapromisingnovelbiomarkerforlymphnodemetastasisinpatientswithgastriccancer
AT jianhuaxu mir21isapromisingnovelbiomarkerforlymphnodemetastasisinpatientswithgastriccancer
AT qili mir21isapromisingnovelbiomarkerforlymphnodemetastasisinpatientswithgastriccancer
AT yuewuguo mir21isapromisingnovelbiomarkerforlymphnodemetastasisinpatientswithgastriccancer
AT qiangzhang mir21isapromisingnovelbiomarkerforlymphnodemetastasisinpatientswithgastriccancer